Central Alabama Nurse Practitioner Association

The U.S. Food and Drug Administration’s (FDA) Bad Ad Program is designed to help healthcare providers (HCPs), including nurse practitioners, recognize potentially false or misleading prescription drug promotion

Posted 4 months ago

The U.S. Food and Drug Administration’s (FDA) Bad Ad Program is designed to help healthcare providers (HCPs), including nurse practitioners, recognize potentially false or misleading prescription drug promotion while also providing them with an easy way to report it to FDA. The FDA encourages all HCPs to learn more about the Bad Ad Program because it may inform their review of information that they come across in prescription drug promotion.

As part of the program, FDA is offering a free 1-hour accredited continuing education (CE) course online and has developed real-life case studies to help HCPs and students learn how to recognize and report potentially false or misleading prescription drug promotion.

We encourage you share and make these valuable resources available to your members. It can be as simple as including the link to the free CE program on your website or in your newsletters. Our goal is to educate as many HCPs as possible about the Bad Ad Program to help ensure that prescription drug promotion is truthful and not misleading. Any effort you make will help!

Resources Available to Share:

• Free 1-Hour FDA Bad Ad CE Course: https://fdaopdpbadad.e-paga.com/
• Real-life Case Studies: https://www.fda.gov/drugs/office-prescription-drug-promotion/educational-case-studies/
• Bad Ad Website: www.FDA.gov/BadAd
• Reporting: BadAd@fda.gov or 855-RX-BADAD

For more information about the Bad Ad Program or to discuss collaborative opportunities please email us at BadAd@fda.gov or call Ankur Kalola at 301-796-4530.

Sincerely,

Ankur Kalola, PharmD
Office of Prescription Drug Promotion

You can reply to this e